SCHEMBL13594

SCHEMBL13594

Brc1ccc2c(c1)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8701960 0.97 PNMT (0.56) —
SCHEMBL749569 0.89 PNMT (0.54) —
SCHEMBL1468326 0.89 PNMT (0.54) —
SCHEMBL18457177 0.88 PNMT (0.48) —
SCHEMBL10182282 0.88 TDP1 (0.48) —
SCHEMBL6192350 0.87 PNMT (0.52) —
SCHEMBL21447111 0.87 PNMT (0.52) —
SCHEMBL22910024 0.87 PNMT (0.52) —
SCHEMBL18746500 0.87 PNMT (0.52) —
Ammonia Solution, Strong SCHEMBL4733194 0.87 PNMT (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078217-A1 TETRACENE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 中国科学院化学研究所 2021-04-29 — — WO claimed
CN-112694388-A Naphthacene derivative and preparation method and application thereof 中国科学院化学研究所 2021-04-23 — — CN claimed
US-12612360-B2 Substituted 6,7-dihydro-5H-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof SANOFI (FR) 2026-04-28 — — US disclosed
EP-3515892-B1 COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC (US) 2026-04-15 — — EP disclosed
EP-4667458-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING SOS1 INHIBITOR AND ANTICANCER DRUG Kanaph Therapeutics Inc. (KR) 2025-12-24 — — EP disclosed
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
US-20250326765-A1 PDE4B INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2025-10-23 — — US disclosed
US-20250263426-A1 PDE4B INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 — — US disclosed
EP-4534540-A1 PDE4B INHIBITOR AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2025-04-09 — — EP disclosed
WO-2025026270-A1 BENZO NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2025-02-06 — — WO disclosed
US-20240400518-A1 SOS1 INHIBITOR AND USE THEREOF CYRUS THERAPEUTICS INC. (KR) 2024-12-05 — — US disclosed
US-5227536-A PROCESS FOR PREPARING HYDROXYBENZOCYCLOBUTENES THE DOW CHEMICAL COMPANY (US) 1993-07-13 — — US disclosed
WO-1993006072-A1 PROCESS FOR PREPARING HYDROXYBENZOCYCLOBUTENES THE DOW CHEMICAL COMPANY (US) 1993-04-01 — — WO disclosed
WO-1993006083-A1 PROCESS FOR PREPARING AMINOBENZOCYCLOBUTENES THE DOW CHEMICAL COMPANY (US) 1993-04-01 — — WO disclosed
US-5196103-A Dielectric polycyclobutarene layer, adhesion, metal carbide interface, sputtering THE DOW CHEMICAL COMPANY (US) 1993-03-23 — — US disclosed
US-5136069-A Reacting with halogenated organic compound in presence of palladium complex catalyst and inorganic hydrogen halide acceptor THE DOW CHEMICAL COMPANY (US) 1992-08-04 — — US disclosed
EP-0323536-A1 Arylcyclobutene/dienophile copolymers THE DOW CHEMICAL COMPANY (US) 1989-07-12 — — EP disclosed
US-4783514-A Polymeric monoarylcyclobutane compositions THE DOW CHEMICAL COMPANY (US) 1988-11-08 — — US disclosed
US-4730030-A Arylcyclobutane/dienophile copolymer THE DOW CHEMICAL COMPANY (US) 1988-03-08 — — US disclosed
US-4724260-A Unsaturated alkyl monoarylcyclobutane monomers THE DOW CHEMICAL COMPANY (US) 1988-02-09 — — US disclosed
Send feedback